Emerging Molecular Therapeutic Targets in Breast Cancer: Pathologic Identification and Clinical Implications
{{output}}
Breast carcinoma represents a biologically heterogeneous group of malignancies with diverse clinical behaviors, highlighting the need for robust molecular markers to support accurate diagnosis, prognosis, and therapeutic decision-making. Histopathologic evalua... ...
